Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remission in rheumatoid arthritis – tapering and withdrawal of DMARDs in sustained remission
2012-005275-14Phase 4Completed
- Sponsor
- Diakonhjemmet Sykehus
- Start
- Feb 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of umbilical cord-derived mesenchymal stem cells (Alliancells) in rheumatoid arthritis (RA), sponsored by Diakonhjemmet Sykehus. Started Feb 2013; status: completed.
02
Drugs
umbilical cord-derived mesenchymal stem cells (Alliancells)
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-005275-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005275-14.